NCT01233687 2017-06-22AMG 102 and Erlotinib for Advanced Non-Small Cell Lung CancerUniversity of PittsburghPhase 1/2 Completed49 enrolled 8 charts
NCT01113398 2015-12-10AMG 102 and Avastin for Recurrent Malignant GliomaDuke UniversityPhase 2 Completed36 enrolled 9 charts